Home > Boards > US OTC > Biotechs >

Falcon Technologies Inc. (FLCN)

FLCN RSS Feed
Add FLCN Price Alert      Hide Sticky   Hide Intro
Moderator: eqinvestor, Taurus69, TKane, PhenixBleu
Search This Board: 
Last Post: 5/24/2019 9:55:27 PM - Followers: 19 - Board type: Free - Posts Today: 2

 



NO KNOWN REVENUE - INADEQUATE DISCLOSURE ON OTC MARKETS - NO KNOWN PRODUCTS - HEAVY DEBT -  EXPECT DILUTION - OTC SHELL RISK FLAG


Eco-Growth Strategies, a Wyoming Corporation

WYOMING REGISTRATION

Falcon Technologies (FLCN) is an Inactive Oregon Corporation. 
Delgado let FLCN go dormant to allow the California Statute of Limitations on debt to run.
He then did a flash reinstatement of FLCN in Oregon to redomicile to Wyoming on February 11, 2019.

CORPORATE ADDRESS IS A VIRTUAL OFFICE IN NEW YORK AS WELL AS DELGADO'S SECURITY LAWYERS OFFICE

90 Broad Street, 2nd FL
New York, NY 10004

 


Warning! 

This company has posted limited financial disclosure through the OTC Disclosure & News Service
or is late in their filing obligations with the SEC.


ACCORDING TO THE 2018 ANNUAL REPORT, WILLIAM J. DELGADO  IS THE SOLE BENEFICIAL SHAREHOLDER
THE ANNUAL REPORT HAS NO REFERENCE TO FUTURE PLANS EVEN THOUGH IT WAS UPLOADED 02/27/19, WELL AFTER THE COMPANY WAS REDOMICILED
TO WYOMING ON FEBRUARY 11, 2019 UNDER THE NAME ECO-GROWTH STRATEGIES.  THE WYOMING ARTICLES OF INCORPORATION DO NOT NAME DELGADO.
THE WYOMING ARTICLES CONTAIN AN AUTHORIZED SHARE COUNT OF 500,000,000 AND PREFERRED SHARE COUNT OF 10,000,000. 

 

OTC MARKETS SECURITY DETAILS

A/S 100,000,000 as of 02/26/2019
O/S 19,531,847 as of 12/31/2018

FLOAT 5,086,101 as of 03/27/2019
Why are the counts not updated on the same day?

WYOMING SECRETARY OF STATE SECURITY DETAILS

A/S 500,000,000 as of 02/11/2019


 

STOCK TRADES BEGAN THE DAY OF THE WYOMING FILING, FEBRUARY 11, 2019,
AND CONTINUED UNTIL THE DAY BEFORE THE DELINQUENT FLCN FILINGS WERE UPLOADED TO OTC MARKETS. 
THAT'S 11 DAYS OF TRADING WITHOUT PUBLIC DISCLOSURE OR NEWS FROM WILLIAM J. DELGADO.
THE SHIFT TO ECO-GROWTH STRATEGIES WAS NOT PUBLIC KNOWLEDGE. THE WYOMING FILING DIDN'T NAME FLCN OR DELGADO.
HOW DID THE EARLY TRADERS LEARN ABOUT THE PENDING TRANSITION?

 
 

2018 ANNUAL REPORT SHOWS
 

ASSETS 1,200
LIABILITIES 1,600,000

NOTES FROM THE 2018 ANNUAL REPORT

(1) All income related assets (receivables, notes, costs in excess of billings) have been zeroed out. There
has been no activity in the last several years in these accounts or the attempts to collect said assets.

(2) All liability accounts have been adjusted accordingly. All of the liabilities, except for notes due to related party,
have exceeded the statute of limitations for the State of California, where such liabilities were incurred.

(3) William J. Delgado, CEO and sole director, on behalf of the shareholders of Falcon Technologies, Inc.,
initiated legal action against three of the former officers and directors of FLCN in 2009. Although legal
counsel was working on a contingency fee arrangement and the probability of success was positive, it was
determined by the company and legal counsel that collectability would be difficult, if not impossible.
The decision not to continue was made mutually by the company and the company’s legal counsel.


The above section will be managed by Moderator PhenixBleu. 
Please review the reasons why posts get deleted.  It's all about the terms each member agrees to upon registering their accounts.

Deletion of Posts
 

=============================================================================================================================================================================


IH USERS: BELOW IS ACTUAL NEWS ANDUNBIASED INFO ON FALCON TECHNOLOGIES


BREAKING NEWS FOR FALCON TECHNOLOGIES, INC. IS OUT !!!!!


 

***APRIL 25, 2019*** Falcon Technologies (Ticker: FLCN) Announces the Filing of a Provisional Patent Application for CBD Formulations to Treat Ulcers


SACRAMENTO, CA / ACCESSWIRE / April 25, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN) announced today that it has filed a provisional patent application with the United States Patent and Trademark Office. The invention is titled "CBD Formulations to Treat Peptic and Gastrointestinal Ulcers".

The pharmaceutical and OTC drug markets to treat ulcers is one of the largest medical markets in the United States. Approximately 4% of all adult Americans suffer from peptic (also called gastrointestinal) ulcers. Peptic ulcers can occur in the stomach, the intestines and even parts of the esophagus. This invention covers all non-cancerous ulcers that occur in the stomach, the intestines and even parts of the esophagus. The most common causes of peptic ulcers are infection with the bacterium Helicobacter pylori (H. pylori) and long-term use of aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) (Advil, Aleve, others).

The provisional patent application number is 62838236. At this time, Falcon will not reveal any details about the provisional patent application except for the fact that the formulation contains CBD and an off-patent ingredient from one of the most well known and well-documented healthcare products in the entire world. The purpose and goal of the patent is to secure patent protection now to operate in what is another multi-billion-dollar market.

This provisional patent application follows Falcon's recent provisional patent application to treat acne with certain CBD formulations. The latest provisional patent application continues Falcon's strategy to gain advantages over potential competition. These advantages may be marketing and sales advantages or formulation advantages such as the one covered by this provisional patent application.

William J. Delgado, Chairman and Chief Executive Officer of Falcon Technologies stated, "We are ecstatic that we can deliver this great news to our shareholders. We are working diligently to gain an advantage over the other companies currently selling CBD products and this second provisional patent application is another example of the progress we are making with our overall corporate strategy."

CBD ( Cannabidiol ) is one of at least 80 active cannabinoids identified in both cannabis and industrial hemp. It is a major constituent of both plants, although the percentages of total composition can vary greatly from strain to strain. Unlike THC (the other prevalent cannabinoid), CBD is non-psychoactive while having the potential to possess a variety of therapeutic properties.

About Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.)

Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) is a nutraceutical company developing a range of CBD-based products. The company's mission is to employ best practice science to source, manufacture and package all of its CBD products from within the United States. The company performs farm site visits and manufacturing site visits and sources its products from only the highest quality hemp farms and processors in North America. The company also aims to launch a line of CBD products specially formulated for animals by the end of 2019.

CBD Disclaimer

The statements made regarding CBD products including our future products have not been evaluated by the Food and Drug Administration. The efficacy of these products and the testimonials made have not been confirmed by FDA- approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act requires this notice.

SAFE HARBOR ACT

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Contact: William J. Delgado
(775) 443-4740
djwllc@hotmail.com

SOURCE: Falcon Technologies

U201904260000




***MARCH 21, 2019*** Provisional Patent Protection was filed for by FLCN for "CBD Formulations to Treat Acne" Patent

 
Falcon Technologies Announces the Filing of a Provisional Patent Application Titled ''CBD Formulations to Treat Acne'' 

SACRAMENTO, CA / ACCESSWIRE / March 21, 
2019 / Falcon Technologies, Inc. (OTC PINK: FLCN) announced today that it has filed a provisional patent application with the United States Patent and Trademark Office. The invention is titled ''CBD Formulations to Treat Acne''. As previously announced, the company expects to have its first products available for sale on or before April 30, 2019. 

Acne is the most common skin condition in the United States. More than 50 million Americans suffer from acne. Acne is a medical problem defined by a persistent and constant inflammation and infection of the sebaceous glands in the skin. Often, acne coexists with other medical problems. Although some medications work for a percentage of people, a large percentage of all acne sufferers suffer from acne for an average period of 5 years or more with little or no relief. A person who suffers from acne can also suffer from self-esteem issues and even depression. No other skin condition affects more Americans or more people in the world than acne. 

The provisional patent application number is 62821332. At this time, Falcon will not reveal any details about the provisional patent application except for the fact that the formulation contains CBD and the purpose and goal of the patent is to secure patent protection now to operate in what is a multi-billion-dollar market. 

William J. Delgado, Chairman and Chief Executive Officer of Falcon Technologies, Inc. stated, ''One of our recently stated goals is to gain a competitive advantage in the CBD market and this provisional patent application is the start of a multi-pronged strategy to do just that.'' 

The Company's short-term goals which are in the process of being fulfilled are the following: 

1.Complete supply chain agreements.
2.Complete branding message. 
3.Finalize initial marketing plans. 
4.Complete initial distribution agreements. 
5.Complete licensing and partnership agreements. 
6.Complete online messaging and presence. 
7.Launch social media campaigns. 
8.Complete competitive advantage initiatives which are of paramount importance to our business plan. 

CBD ( Cannabidiol ) is one of at least 80 active cannabinoids identified in both cannabis and industrial hemp. It is a major constituent of both plants, although the percentages of total composition can vary greatly from strain to strain. Unlike THC (the other prevalent cannabinoid), CBD is non-psychoactive while having the potential to possess a variety of therapeutic properties. 

About Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) 

Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) is a nutraceutical company developing a range of CBD-based products. The company's mission is to employ best practice science to source, manufacture and package all of its CBD products from within the United States. The company performs farm site visits and manufacturing site visits and sources its products from only the highest quality hemp farms and processors in North America. The company also aims to launch a line of CBD products specially formulated for animals by the end of 2019. 

CBD Disclaimer 

The statements made regarding CBD products including our future products have not been evaluated by the Food and Drug Administration. The efficacy of these products and the testimonials made have not been confirmed by FDA- approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act requires this notice. 

SAFE HARBOR ACT 

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise. 

Contact: 

William J. Delgado 

djwllc@hotmail.com

775-443-4740

SOURCE: Falcon Technologies
 
 
***MARCH 18, 2019*** Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) Announces Entry into the CBD Market 


SACRAMENTO, CA / ACCESSWIRE / March 18,2019 / Falcon Technologies, Inc. (OTC PINK: FLCN) announced today its immediate entry into the CBD market. The company's short-term focus will be on the marketing and sale of topical, high strength applications of CBD. Shortly thereafter, the company also plans on launching a high strength CBD hemp oil. The company expects to have its first products available for sale on or before April 30, 2019.

The Company's short-term goals which are in the process of being fulfilled are the following:

Complete supply chain agreements.
Complete branding message.
Finalize initial marketing plans.
Complete initial distribution agreements.
Complete licensing and partnership agreements.
Complete online messaging and presence.
Launch social media campaigns.
Complete competitive advantage initiatives which are of paramount importance to our business plan.


CBD ( Cannabidiol ) is one of at least 80 active cannabinoids identified in both cannabis and industrial hemp. It is a major constituent of both plants, although the percentages of total composition can vary greatly from strain to strain. Unlike THC (the other prevalent cannabinoid), CBD is non-psychoactive while having the potential to possess a variety of therapeutic properties.


William J. Delgado, Chairman and Chief Executive Officer of Eco-Growth Strategies, Inc. commented, "The market for CBD is one of the most rapid growth markets in the United States. Our plan is to offer moderately priced CBD products. All of our products and CBD will be sourced from U.S. based farms after we perform site visits to ensure the quality of the product that we will market and sell to the public."

Mr. Delgado added, "We are building what we believe will be a significant competitive advantage over the other CBD product companies and we reveal our position to all our shareholders shortly."


About Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.)


Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) is a nutraceutical company developing a range of CBD-based products. The company's mission is to employ best practice science to source, manufacture and package all of its CBD products from within the United States. The company performs farm site visits and manufacturing site visits and sources its products from only the highest quality hemp farms and processors in North America. The company also aims to launch a line of CBD products specially formulated for animals by the end of 2019.


CBD Disclaimer


The statements made regarding CBD products including our future products have not been evaluated by the Food and Drug Administration. The efficacy of these products and the testimonials made have not been confirmed by FDA- approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Actrequires this notice.

SAFE HARBOR ACT

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.


Contact: William J. Delgado

djwllc@hotmail.com

75-443-4740

SOURCE: Falcon Technologies


 

FALCON TECHNOLOGIES - A CBD PRODUCT COMPANY - FOCUSED ON THE FUTURE

FALCON TECHNOLOGIES, INC. IS A PUBLICLY-HELD OTC COMPANY TRADING UNDER STOCK TICKER: FLCN

CONTACT US: 6220 MAIN AVE #2 ORANGEVILLE CA 95662; PHONE 916-838-8833; EMAIL djwllc@hotmail.com







Falcon Technologies, Inc. a/k/a Eco-Growth Strategies, Inc. is a nutraceutical company developing a range of CBD products: Company Profile: https://www.otcmarkets.com/stock/FLCN/profile

4/25/2019 News Out: 
Falcon Technologies (Ticker Symbol: FLCN) Announces the Filing of a Provisional Patent Application for CBD Formulations to Treat UlcersPress Release

Check it out:  https://www.otcmarkets.com/stock/FLCN/news/Falcon-Technologies-Announces-the-Filing-of-a-Provisional-Patent-Application-for-CBD-Formulations-to-Treat-Ulcers?id=225942


3/21/2019 News Out:https://www.otcmarkets.com/stock/FLCN/news/Falcon-Technologies-Announces-the-Filing-of-a-Provisional-Patent-Application-Titled-CBD-Formulations-to-Treat-Acne?id=222179


3/18/2019 News Outhttps://www.otcmarkets.com/stock/FLCN/news/Falcon-Technologies-Inc-aka-Eco-Growth-Strategies-Inc-Announces-Entry-into-the-CBD-Market?id=221731




Further updates on CBD products entering the market place in 2019 will be posted as released! Falcon Technologies, INc., a CBD company, is looking forward to future growth and value!

 



FALCON TECHNOLOGIES, INC. - OTC TICKER SYMBOL: FLCN


 


The IH Rules of the Road (IH Source Documents) covering User Posting on IH Stock Boards

IH Terms of Service (TOS) on users and posts:  https://investorshub.advfn.com/boards/terms.aspx

IH Handbook contains rules regarding posting:   http://ihwiki.advfn.com/index.php?title=Handbook



Here's to a pleasant experience exploring and using the FLCN (Falcon Technologies) Stock Board! Please contact IH Admin with any negative experiences. Thank you.






.

FLCN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#634  Sticky Note https://www.otcmarkets.com/stock/FLCN/news/Falcon-Technologies-Announces-the-Fil MLR_Lite 04/25/19 08:11:32 AM
#507  Sticky Note $flcn websites closed. No reply from email. No Taurus69 04/16/19 06:10:15 AM
#131  Sticky Note Forte Capital Partners LLC vs. William J. Delgado PhenixBleu 03/15/19 10:47:36 AM
#124  Sticky Note Company Moving Into CBD Business With Market Cap eqinvestor 03/14/19 10:06:36 AM
#773   $flcn pps going to crash. $.004 Taurus69 05/24/19 08:04:56 PM
#772   Someone giving their shares away at .12 range hockeypond 05/15/19 07:58:48 PM
#771   Is Delgado wearing a disguise? He's the PhenixBleu 05/15/19 09:52:13 AM
#770   Falcon Technologies Announces Its Participation and Attendance at eqinvestor 05/15/19 08:33:27 AM
#769   $FLCN Falcon Technologies Announces Its Participation and Attendance at deri21 05/15/19 08:22:10 AM
#767   No relationship between MEC and FLCN except that PhenixBleu 05/14/19 10:18:13 AM
#766   We are current and I know it's frustrating eqinvestor 05/14/19 09:54:12 AM
#765   Delgado filed a false document with Oregon? Is PhenixBleu 05/14/19 09:05:14 AM
#764   BTW, if you would do your homework, you eqinvestor 05/14/19 08:10:27 AM
#763   Wow, wrong again. And that will be proven eqinvestor 05/14/19 08:07:11 AM
#762   Wow...last Wednesday, May 8, William J. Delgado filed PhenixBleu 05/14/19 06:27:34 AM
#761   $flcn $.0001 companies in default, Delgado debacle. Owes Taurus69 05/14/19 12:47:39 AM
#760   Fully registered in Oregon. Public records prove it. eqinvestor 05/13/19 09:27:33 PM
#759   The company is registered in Oregon. flight director 05/13/19 04:12:16 PM
#758   How is tis related to this unregistered Oregon ticker? PhenixBleu 05/13/19 03:53:54 PM
#757   No products on shelves. No revenue. No disclosure PhenixBleu 05/13/19 03:51:28 PM
#756   There are no rehabs that would allow Mr. PhenixBleu 05/13/19 01:50:17 PM
#755   That is correct. He is a sad piece eqinvestor 05/13/19 12:12:05 PM
#754   But his minions are out in force on AfternoonDelight 05/13/19 12:05:41 PM
#753   It’s an all time low for a once AOBiz 05/13/19 12:03:45 PM
#752   I have no idea what you're talking about. PhenixBleu 05/13/19 09:13:25 AM
#751   Wouldn't that be sweet revenge for MEC shareholders? PhenixBleu 05/13/19 08:46:57 AM
#750   I guess there is massive pressure on Edward eqinvestor 05/13/19 01:25:50 AM
#749   $flcn Delgado threw maciora under the bus in Taurus69 05/12/19 11:01:22 PM
#748   I submitted complaints to the SEC. So, PhenixBleu 05/11/19 09:14:25 AM
#747   $flcn are these the three that are being Taurus69 05/11/19 07:28:51 AM
#746   Wrong again man. Delgado, Ken Maciora and Rod PhenixBleu 05/10/19 09:35:46 PM
#745   By a person who is sentenced to jail eqinvestor 05/10/19 06:22:31 PM
#744   All that gibberish has nothing to do with PhenixBleu 05/10/19 06:20:59 PM
#743   Well, you're wrong again. I have much higher PhenixBleu 05/10/19 06:14:48 PM
#742   Sure he does and the reason why is eqinvestor 05/10/19 11:40:55 AM
#741   Post the court order. I am certain you eqinvestor 05/10/19 09:33:36 AM
#740   Facts are easy to verify. Use my PhenixBleu 05/10/19 08:57:57 AM
#739   Good try. Ed Starrs has been sentenced to prison. eqinvestor 05/10/19 08:04:27 AM
#738   The CA Prison System doesn't have an inmate PhenixBleu 05/10/19 06:13:51 AM
#736  Restored Ed Starrs has been sentenced to prison eqinvestor 05/09/19 06:59:16 PM
#735   Mr. Starrs has nothing to do with Delgado's PhenixBleu 05/09/19 04:30:07 PM
#734   What has been established is that Mr. Delgado eqinvestor 05/09/19 02:47:56 PM
#733   And what he was given? eqinvestor 05/09/19 02:27:28 PM
#732   We've established Delgado was in charge of Investor PhenixBleu 05/09/19 01:49:58 PM
#731   No sir, that is an allegation. A director eqinvestor 05/09/19 10:26:11 AM
#730   I disagree on all counts. Delgado was Termed PhenixBleu 05/09/19 10:16:26 AM
#728   This makes no sense. Are you confusing me PhenixBleu 05/09/19 09:59:40 AM
#726   I have tried patches and wouldn't use them PhenixBleu 05/09/19 09:20:31 AM
#725   News on Falcon eqinvestor 05/09/19 09:09:41 AM
#723   Delgado hasn't updated the Security Details. This PhenixBleu 05/09/19 08:51:34 AM
#722   $FLCN News. deri21 05/09/19 08:25:19 AM
#721   This is a very interesting stock! Never AfternoonDelight 05/09/19 07:57:55 AM
#719   Hope uptrend continues' emit 05/07/19 12:41:16 AM
#718   $flcn $.27 Delgado’s debacle. 50% drop today. Bills Taurus69 05/03/19 04:45:37 PM
PostSubject